Fakultäts-Retreat (intern)
O-Werk Bochum
Medical Faculty of the Ruhr-University Bochum
We are shaping the future of medicine
from the Ruhr region to Ostwestfalen-Lippe.
University Medical Center Bochum, which consists of the Faculty of Medicine and eight supporting clinics, supported by numerous teaching hospitals, we combine practical teaching, innovative research and the direct application of our findings in clinical practice. Together, we are working on the cutting-edge medicine of tomorrow - for committed students, a sustainable society and strong healthcare provision throughout the region.
The Faculty of Medicine
Find out more about our organizational structure, our goals and values as well as the right contact persons for your concerns.
Study medicine
The curriculum of our integrated reform medicine (iRM) degree program places particular emphasis on interdisciplinarity and practical relevance. This flexible and future-oriented education optimally prepares our students for the medical challenges of tomorrow.
Research at the RUB
Our research excels in basic research, translational science, and clinical studies, with a focus on protein sciences, oncology, and neuroscience. Following the 'From Bench to Bedside' approach, we translate laboratory findings directly into clinical applications, setting global standards.
Clinical partner
Through the diversity of our partner hospitals and academic teaching hospitals, we position ourselves strongly in clinical education, research, and patient care. This close collaboration makes us one of the largest and most efficient university hospitals in Germany, ensuring excellent training and top-quality patient care.
Current dates & events
-
-
FoRUM Conference
Marien Hospital Herne
-
2. Bochumer Symposium für Diversitätsmedizin
10:00 o'clockBeckmanns Hof
Latest news from the faculty
Wolff Schmiegel honored by the German Cancer Society
On the occasion of its anniversary, the German Cancer Society awarded the Ernst von Leyden Prize for the first time. The inaugural recipient is Prof. Dr. Wolff Schmiegel, emeritus director of Gastroenterology/Hepatology at UK Bergmannsheil. Schmiegel is regarded as a pioneer of evidence-based cancer therapy, and through his commitment he has significantly shaped guidelines, certifications, and the structures of modern oncology in Germany.
With deep sorrow, we bid farewell to Prof. Dr. med. Wolfgang Opferkuch (April 20, 1932 – September 2, 2025)
As an internationally renowned microbiologist and twice Dean of the Faculty of Medicine at Ruhr University Bochum, he shaped the faculty, the “Bochum Model,” and entire generations of researchers. Through his work on antibiotic resistance, the complement system, and Helicobacter pylori, he set standards far beyond Bochum. His legacy endures—along with the lasting marks he left through his passion and vision.
Guideline on Respiratory Infections in Blood Cancer Patients Updated
A new European guideline provides well-founded answers to pressing questions regarding the management of respiratory infections in patients with blood cancer. Based on insights from a decade of research, it offers a comprehensive overview of risk assessment, diagnostics, hygiene measures, treatment, and vaccination strategies – published in the renowned journal The Lancet Infectious Diseases. Individuals with leukemia and related conditions are particularly vulnerable, as their immune systems are weakened by both the disease and its treatment. For the first time, the updated recommendations systematically evaluate all relevant viruses that can cause community-acquired respiratory tract infections. The goal is to give clinicians clear guidance in everyday practice and to improve protection for those affected. Lead author of the guideline is Prof. Dr. Marie von Lilienfeld-Toal from Ruhr University Bochum, who played a key role in the European Conference on Infections in Leukemia (ECIL).
Use immunotherapy for anti-IgLON5 disease as early as possible
Around four million people in Germany have survived cancer, yet many face lasting physical and emotional challenges after their treatment ends. Afagh Hassani, a cancer survivor and human genetics specialist at Ruhr University Bochum, knows this struggle firsthand. To bridge the gap in post-cancer care, she co-founded AfterBattle—a holistic app designed to support survivors with tailored nutrition advice, mindfulness exercises, and cutting-edge epigenetic tools. Recently recognized as one of the top three start-ups at Ruhr University Bochum’s WORLDFACTORY Demo Days 2025, AfterBattle offers cancer survivors a trusted, easy-to-use digital companion to navigate life after cancer—and never feel alone.